NCT05649319Completed
ERAS on Postoperative Recovery After Laparoscopic Distal Gastrectomy
Effectiveness of Enhanced Recovery After Surgery (ERAS) on Postoperative Recovery After Laparoscopic Distal Gastrectomy: An Open-labeled Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 1 Jan 2025
Brief summary (registry, in English)
This prospective, randomized, open-labeled study is designed to evaluate the impact of enhanced recovery after surgery (ERAS) protocol on postoperative quality of recovery in patients undergoing laparoscopic distal gastrectomy. We hypothesize that our ERAS protocol can significantly improve the postoperative quality of recovery in patients with laparoscopic distal gastrectomy.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 98 (actual)
- First submitted
- 28 Nov 2022
- Start date
- 3 Feb 2023
- Primary completion date
- 7 Jun 2024
- Lead sponsor
- Seoul National University Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT05649319
What you commit to
- Study type: Interventional
- Participants enrolled: 98
- From 3 Feb 2023 to the primary completion date, 7 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Gastrectomy with combined resection of other organs
Other illness
- Patients with history of upper abdominal surgery
- Allergies to anesthetic or analgesic medications (fentanyl, ropivacaine, acetaminophen, NSAIDs)
- Medical or psychological disease that can affect the treatment response
Other
- Patients with chronic pain
Who the study is looking for
- Patients scheduled to undergo elective laparoscopic distal gastrectomy
- American Society of Anesthesiologists (ASA)physical classification I-II
- ECOG Performance Status Scale 0 or 1
- Willingness and ability to sign an informed consent document
Age in the registry: 19 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul National University Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.